Teslina 5 Tablet
Marketer
Mexican Wave Pharma
Salt Composition
Linagliptin (5mg)
Overview Teslina 5 Tablet
Diabetic patients may find relief with Glucobal 5, a medication employed in managing type 2 diabetes. Optimal blood sugar control is achieved when combined with a balanced diet and regular physical activity, thus mitigating risks of serious diabetic complications, such as impaired vision and kidney dysfunction. Glucobal 5 is typically prescribed when dietary adjustments and exercise, or other medications, prove inadequate. Your physician may prescribe it solely or in conjunction with other anti-diabetic treatments. Administration is flexible, with or without food, and dosage is tailored to individual needs and blood sugar readings. Adherence to your doctor's prescribed regimen is crucial; discontinuation should only occur under medical guidance. Maintaining the recommended diet and exercise program is vital for effective diabetes management, as lifestyle choices significantly impact blood sugar control. Hypoglycemia is a common side effect, characterized by symptoms such as sweating, dizziness, faintness, and lightheadedness. Carrying glucose tablets can help manage these symptoms. Nasopharyngitis is another possible side effect. Report any persistent or concerning side effects to your doctor. Prior to commencing treatment, inform your physician of any existing kidney, heart, or pancreatic conditions. Potential drug interactions necessitate disclosure of all medications currently being taken. Pregnant or lactating individuals should consult their doctor before initiating treatment. Alcohol consumption should be moderated as it can heighten the risk of hypoglycemia. Regular monitoring, including kidney function and blood glucose levels, will ensure treatment efficacy.
Primary Ingredients of Teslina 5 Tablet
No text provided to rephrase.
Uses of Teslina 5 Tablet
Managing type 2 diabetes
Major Benefits of Teslina 5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Teslina 5 Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Teslina 5 Tablets can be taken with or without food, though consistent timing is recommended.
Common Side effects of Teslina 5 Tablet:
- Hypoglycemia (low blood glucose level)
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Cough
- Vomiting
- Diarrhea
- Constipation
How to use Teslina 5 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. Teslina 5 Tablets can be administered with or without food, although consistent timing is recommended.
How Teslina 5 Tablet works:
Teslina 5 Tablets are used to manage diabetes. Their mechanism involves stimulating insulin secretion from the pancreas and suppressing hyperglycemic hormones. The result is lower blood glucose, both before and after eating.
SAFETY ADVICE
AlcoholUNSAFE
Combining Teslina 5 Tablet and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Data on Teslina 5 Tablet use in pregnancy are lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Teslina 5 Tablet use while breastfeeding is lacking. Seek your physician's advice.
DrivingSAFE
Driving ability is typically unaffected by Teslina 5 Tablet.
KidneySAFE IF PRESCRIBED
Kidney disease patients can safely take Teslina 5 Tablet without a dosage change. Nevertheless, exercise caution when prescribing Teslina 5 Tablet to individuals with ESRD or undergoing dialysis.
LiverSAFE IF PRESCRIBED
Patients with liver disease can generally use Teslina 5 Tablet without dose modification. Nevertheless, its use is contraindicated in individuals with severe hepatic impairment.
What if you forget to take Teslina 5 Tablet :
Should you forget a Teslina 5 Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Teslina 5 Tablet
| Label | Value |
|---|---|
| Chemical Type | Purine-quinazoline hybrid |
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
| Actions | Dipeptidyl peptidase-4 inhibitors |



